BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » HSCs » Page 4

Hematopoietic Stem Cells (HSCs)

What Is Multiple Sclerosis? | FAQs

October 26, 2018 By Cade Hildreth (CEO)

Feature | What Is Multiple Sclerosis? | FAQs

Learn more about multiple sclerosis treatment and how stem cells can help in treating this condition here.

in this article:

  1. What Is Multiple Sclerosis?
  2. How Do You Treat Multiple Sclerosis?
  3. How Much Does It Cost for MS Treatment?
  4. What Is the Role of Stem Cells in Multiple Sclerosis Treatment?
  5. Where To Go For MS Stem Cell Treatment
  6. What Are the Factors to Consider That Place a Person at a Higher Risk for MS?
  7. Multiple Sclerosis Research

[Read more…]

Filed Under: HSCs, Stem Cells

Hematopoietic Stem Cells: What Diseases Can these Stem Cells Treat?

October 19, 2018 By Cade Hildreth (CEO)

Hematopoietic Stem Cells

Hematopoietic stem cells (HSCs) are defined as stem cells that have a preference for becoming cells of the blood and immune system, such as white blood cells, red blood cells, and platelets. Found in the peripheral blood and bone marrow, hematopoietic stem cells are also present in plentiful supply within the umbilical cord blood of newborn babies.

For the past thirty years, cord blood has been used within transplant medicine, including for the treatment of leukemia and other blood diseases. For most conditions in which a bone marrow or peripheral blood stem cell transplant is an option, a cord blood transplant is a potential alternative.

Hematopoietic Stem Cells

In this article:

  • Human Cord Blood Cells
  • Common Diseases Treatable with Cord Blood Transplant
  • Allogeneic and Autologous Transplants
  • Diseases Treatable with Hematopoietic Stem Cell Transplant in the Future

[Read more…]

Filed Under: Cord Blood, HSCs

When Did Cord Blood Banking Start? Landmark Events in Cord Blood & Tissue

October 11, 2018 By Cade Hildreth (CEO)

Banking Cord Blood | When Did Cord Blood Banking Start?

The global cord blood industry came into existence in the early 1990’s with the formation of several leading cord blood banks in the USA, followed by the establishment of cord blood banks across the globe. However, the history of cord blood stem cell transplantation begins much earlier than that.

The History of Banking Cord Blood

In this article:

  • Umbilical Cord Stem Cells
  • Cord Blood Stem Cells Transplant
  • Public Cord Blood Banking
  • Private Cord Blood Banking
  • Cord Blood Registry
  • Cord Blood Banking Companies in Asia
  • Banking Umbilical Cord Tissue
  • Placental Blood and Tissue Banking
  • Menstrual Fluid Stem Cells
  • Saving Cord Blood and Tissue
  • Diversity in Stem Cell Banking
  • Cord Blood Expansion Technologies

[Read more…]

Filed Under: Cord Blood, HSCs Tagged With: cord blood, cord tissue, placenta

Could NiCord® by Gamida Cell Introduce a Paradigm Shift to HSCT?

August 17, 2018 By Cade Hildreth (CEO)

NiCord

Gamida CellGamida Cell is an Israeli company specializing in cellular and immune therapies for the treatment of cancer and orphan genetic diseases. The company is developing a diverse clinical pipeline based on its proprietary NAM technology platform. It lead program, NiCord®, is now in Phase 3 development for allogeneic bone marrow transplantation.

NiCord® was granted Breakthrough Therapy Designation by the FDA, as well orphan drug designation by the European Medicines Agency (EMA). [Read more…]

Filed Under: Cord Blood, HSCs Tagged With: gamida cell, NiCord

Cord Blood Industry Trends – Clinical Trials, Publications, Patents, Grants, & More

May 30, 2018 By Cade Hildreth (CEO)

With the global cord blood banking industry maturing and consolidating over the past five years, it is more important than ever to be well-educated about cord blood industry trends. There are now fewer market players, because numerous small cord blood banks have either been acquired or gone out of business.

However, this era of maturation and consolidation has had as many benefits to surviving cord blood banks as drawbacks. On average, the remaining market participants are now larger, stronger, better capitalized, and storing larger quantities of cord blood and tissue units than when the market was more fragmented.

[Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: cord blood, market research

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 32
  • Next Page »

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Marathon Products

Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • US Cord Blood and Cord Tissue Storage Rates Rates of U.S. Cord Blood and Cord Tissue Storage - Historical and Projected
    Rated 0 out of 5
    $197
  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • BioInformant Audience Reach BioInformant's Audience with Your Press Announcement
    Rated 0 out of 5
    $397 $297

Featured Posts

AASCP Dr Camillo Ricordi

AASCP Hosting Lecture on Groundbreaking Trial That May Reduce Risk of Death in Severe COVID 19 Patients

Biotech investing | stem cell stocks

Stem Cell Stocks: A Complete List from “A” to “Z”

Stem cell conferences

The Complete Guide To Virtual Stem Cell Conferences in 2021

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.